Carbamazepine toxicity: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "== " to "==") |
Neil.m.young (talk | contribs) (Text replacement - "==Treatment==" to "==Management==") |
||
| Line 19: | Line 19: | ||
*Levels do not accurately correlate w/ clinical severity | *Levels do not accurately correlate w/ clinical severity | ||
== | ==Management== | ||
*GI detox | *GI detox | ||
**[[Activated Charcoal]] (if presents w/in 1hr of ingestion) | **[[Activated Charcoal]] (if presents w/in 1hr of ingestion) | ||
Revision as of 06:35, 9 July 2016
Background
- Has anticholinergic and antiepileptic effects
- Therapeutic concentration: 4-12
Clinical Features
- May be delayed and follow crescendo-decrescendo course (due to delayed GI motility)
- CNS
- Ataxia
- Nystagmus
- Coma
- Anticholinergic Toxicity
- CV
- Dysrhythmias are rare but may occur
- Wide QRS
- QT Prolongation
Diagnosis
- Levels do not accurately correlate w/ clinical severity
Management
- GI detox
- Activated Charcoal (if presents w/in 1hr of ingestion)
- Dialysis is effective (if needed)
Disposition
- Consider discharge for patient with decreasing levels (measured few hrs apart) and is asymptomatic